1 Stock That Is Not Worth Chasing in 2022

As demand for vegan alternatives for meat-based products grows, Beyond Meat’s (BYND) innovative business model has enabled them to grab the market. However, the company’s lack of profitability and lofty valuation has raised significant investor concerns over its prospects. In addition, poor analysts’ ratings further make the stock’s near-term prospects look gloomy. So, we think…

These 3 Stocks Won’t Trade Under $100 For Long

The slumbering bear market of 2022 has been rough on all sectors (except the energy sector) and most individual stocks. MarketBeat.com – MarketBeat The silver lining, however, is that the shares of a lot of fundamentally sound companies are on sale. Names that have fallen out of favor with the market yet still have solid…

Is it Time to Cash Out Novavax Stock?

Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S. The U.S. FDA approval was granted on July 13th making it the fourth COVID-19 vaccine approved in the U.S., but still needs the CDC approval to…

3 Simple Ways to Motivate a Remote Workforce

Opinions expressed by Entrepreneur contributors are their own. We’re over two years into the Covid-19 pandemic, and it seems that society has returned to some semblance of normal. It is a new normal, certainly, but at least we are no longer scrambling to buy up rolls of toilet paper or fashioning make-shift masks out of…